Single inhaler triple therapy in COPD – all that glitters is not gold

Abstract

Dear Editor, The recent studies on combination triple therapy of inhaled corticosteroid, long acting beta2 agonist and long-acting muscarinic antagonist (ICS-LABA-LAMA) in COPD have consistently demonstrated an improvement in exacerbation frequency and/or improvement of lung function...

Keywords

• COPD
• airway diseases
• triple therapy
• inhaled steroids
• pharmacology